Cite

HARVARD Citation

    Landfeldt, E. et al. (2020). Improvements in health status and utility associated with ataluren for the treatment of nonsense mutation Duchenne muscular dystrophy. Muscle & nerve. 61 (3), pp. 363-368. [Online]. 
  
Back to record